Episode 24029
Psychedelics... Prodrugs... What else? Dr. Sam Clark, CEO of Terran Biosciences
BioTech Nation ... with Dr. Moira Gunn · Moira Gunn
July 17, 202417m 48s
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
This week on BioTech Nation, Dr. Sam Clark, CEO of Terran Biosciences, discusses prodrugs—modified drugs that improve absorption and efficacy. Also, Terran Biosciences is developing non-hallucinogenic psychedelics by blocking the serotonin 2A receptor and manufacturing psychedelics like LSD and psilocybin for research. Dr. Clark highlights Terran's innovative, tech-inspired approach to rapidly develop affordable medications.
Topics
prodrugspsychedelicsserotonin 2A receptornon-hallucinogenicdrug absorptionTerran BiosciencesDr. Sam ClarkLSDpsilocybinclinical researchbiotech innovationaffordable medicationstech-inspired approachdrug developmentmental health treatmentstherapeutic benefits